We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

115 hedge funds and large institutions have $74M invested in Sanofi Contingent Value Rights in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less funds holding

Funds holding: 118 → 115 (-3)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

19% less capital invested

Capital invested by funds: $91.5M → $74M (-$17.4M)

22% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 18

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
115
Holders Change
-3
Holders Change %
-2.54%
% of All Funds
3.07%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
7
Increased
14
Reduced
18
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EM
Elliott Management
New York
+$6.02M
2
OAM
Oxford Asset Management
United Kingdom
+$1.05M
3
CLOS
Compagnie Lombard Odier SCmA
Switzerland
+$699K
4
LCM
Lonestar Capital Management
California
+$365K
5
JP Morgan Chase
JP Morgan Chase
New York
+$34.8K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$6.22M
2
WA
Whitebox Advisors
Minnesota
-$5.92M
3
PC
Pomelo Capital
New York
-$559K
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$260K
5
Millennium Management
Millennium Management
New York
-$163K
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
1
Whitebox Advisors
Minnesota
$13.7M -$5.92M -8,458,526 -30%
FTCM
2
Fir Tree Capital Management
New York
$12.9M – – –
MCM
3
Mason Capital Management
New York
$9.96M – – –
EM
4
Elliott Management
New York
$5.84M +$6.02M +8,614,000 New
CPM
5
Chesapeake Partners Management
Maryland
$5.66M – – –
Allianz Asset Management
6
Allianz Asset Management
Germany
$4.09M -$3.29K -4,704 -0.1%
OAM
7
Oxford Asset Management
United Kingdom
$3.4M +$1.05M +1,500,000 +43%
GCM
8
Gruss Capital Management
New York
$2.71M – – –
COPPSERS
9
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$2.15M – – –
CL
10
CSS LLC
Illinois
$1.74M – – –
LCM
11
Lonestar Capital Management
California
$1.24M +$365K +521,700 +40%
Citigroup
12
Citigroup
New York
$1.05M – – –
Brown Advisory
13
Brown Advisory
Maryland
$963K – – –
Millennium Management
14
Millennium Management
New York
$899K -$163K -232,929 -15%
MFP
15
Michael F. Price
$864K – – –
UOC
16
UBS O'Connor
Illinois
$822K +$5.93K +8,482 +0.7%
CLOS
17
Compagnie Lombard Odier SCmA
Switzerland
$678K +$699K +1,000,000 +1,190,476%
PC
18
Pomelo Capital
New York
$542K -$559K -799,076 Closed
Adage Capital Partners
19
Adage Capital Partners
Massachusetts
$417K – – –
BMO
20
Beck Mack & Oliver
New York
$347K -$4.23K -6,050 -1%
GF
21
Gabelli Funds
New York
$343K -$69.9K -100,000 -16%
ACM
22
Akanthos Capital Management
California
$339K – – –
Bank of America
23
Bank of America
North Carolina
$327K -$1.03K -1,475 -0.3%
FCM
24
Farmstead Capital Management
New Jersey
$312K – – –
TA
25
Teton Advisors
New York
$271K – – –
1
2 3 4 5

GCVRZ Hedge Fund Activity: Q1 2015 in Review

115 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2015, worth a combined $74M — down 19% from $91.5M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of GCVRZ and 7 opened new positions — a net loss of 1 holder — while 18 trimmed existing stakes and 14 added.

The largest buyer was Elliott Management, opening a new position worth an estimated $6.02M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $6.22M sold.

  • 115 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2015, down from 118 in Q4 2014.
  • Funds reported $74M of Sanofi Contingent Value Rights stock for Q1 2015, down 19% quarter-over-quarter.
  • 7 funds opened new Sanofi Contingent Value Rights positions in Q1 2015 and 8 closed out, a net change of -1 holder.
  • The largest Sanofi Contingent Value Rights buyer in Q1 2015 was Elliott Management, an estimated $6.02M added.
  • The largest Sanofi Contingent Value Rights seller in Q1 2015 was Sphera Funds Management, an estimated $6.22M sold.

Based on aggregated 13F filings for Q1 2015.